… , current experience seems quite promising, especially in patients with severe thrombocytopenia.
Table 2 summaries our experience with cyclophosphamide and/or rituximab in very life-…

… and clinical experience with this … -experienced (36). These differences between observational
studies and RCTs may be due to the heterogeneity of the SLE population in the real-world …

… be a critical redefinition of an APS gold standard, for instance derived from the APS ACTION
registry that will include not only current APS patients but also those with antiphospholipid …

… Antiphospholipid syndrome (APS) is characterized by the presence of persistent positivity
for antiphospholipid antibodies (aPL) in patients who experience recurrent pregnancy …

… Hughes Syndrome Foundation, for her invaluable help and support in conducting the study
as well as to the Hughes Syndrome … of all the Hughes Syndrome Foundation members who …

… Antiphospholipid syndrome (APS) is a systemic autoimmune disease characterized by
obstetric morbidity, arterial and/or venous thrombosis in the presence of antiphospholipid …

… Limitations of the study: our experience was gained exclusively in a rheumatological context,
therefore it mainly includes patients with misdiagnosis of TAPS as SLE or cardiovascular …

… Antiphospholipid syndrome (APS) is currently recognized as … , ranging from asymptomatic
antiphospholipid (aPL) carriers to life-… Regarding patients who experience a pregnancy failure …

… Therefore, our findings provide a real-life experience with rivaroxaban in the setting of APS.
… The 10 patients who did not experience recurrent VTE are still managed with rivaroxaban in …

… VKAs constitute the conventional therapy for the treatment and secondary thromboprophylaxis
of thrombotic antiphospholipid syndrome (APS), but are often problematic, owing to the …